Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 26 May 2022 for Genocea Biosciences, INC., €208.
Filing timeline
BuySaleRaymond D. Stapleton Jr.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Raymond D. Stapleton Jr.: trading record in brief
All filings by Raymond D. Stapleton Jr. on record concern Genocea Biosciences, Inc., in the capacity of senior executive. We count 2 filings; the first trade dates from 15 March 2022 and the latest from 25 May 2022.
Sales make up the whole of the open-market record (1 sale, €208). Besides market trades, the filings include 1 share grant.
The latest filing, published on 26 May 2022, reports an open-market sale of €208 in Genocea Biosciences, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Raymond D. Stapleton Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,500 shares@ US$0.089100.0% of flowCommon StockSEC:0001457612-22-000062:0
43,750 shares0Common StockSEC:0001457612-22-000034:0
2 of 2 declarations
